NCT00677222 - Safety Study of AMI MultiStem® to Treat Heart Attacks | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

March 31, 2010

Study Completion Date

February 29, 2012

Conditions

Acute Myocardial Infarction

Interventions

BIOLOGICAL

AMI MultiStem®

AMI MultiStem® administered via catheter into peri-vascular space of the target vessel, 2-5 days post PCI. There will be 3 dose escalation cohorts, 6 patients per cohort.

Trial Locations (7)

10032

Columbia University Medical Center, New York

16507

Hamot Medical Center, Erie

35211

Cardiology PC, Birmingham

44109

Metro Health, Cleveland

44195

Cleveland Clinic, Cleveland

46260

The Care Group, Indianapolis

48202

Henry Ford Hospital, Detroit